LOGIN  |  REGISTER
C4 Therapeutics
Astria Therapeutics

Viemed Healthcare to Present at Stifel 2023 Healthcare Conference

November 07, 2023 | Last Trade: US$9.21 0.42 4.78

LAFAYETTE, La., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will participate in the Stifel 2023 Healthcare Conference on November 15, 2023, in New York, New York at the Lotte New York Palace Hotel, located at 455 Madison Ave.

Casey Hoyt, CEO, and Todd Zehnder, COO, will conduct a presentation that will cover key areas of Viemed’s business at 1:15pm EST. Additionally, investors that are registered for the conference will have the ability to request one-on-one meetings with management.

The presentation webcast and presentation slides will be available live and can be accessed through the following link: https://wsw.com/webcast/stifel83/vmd.to/2368752

Following the event, a replay of the presentation will remain available for 90 days.

ABOUT VIEMED HEALTHCARE, INC.

Viemed is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. Visit our website at www.viemed.com.

For further information, please contact:

Glen Axelrod
Bristol Capital
905-326-1888
This email address is being protected from spambots. You need JavaScript enabled to view it.

Todd Zehnder
Chief Operating Officer
Viemed Healthcare, Inc.
337-504-3802
This email address is being protected from spambots. You need JavaScript enabled to view it.

Viking Therapeutics

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB